Enspire DBS Therapy
PrivateLast Round
Series B
Extension
Jan 13, 2026
Total Funding Raised
$30.4M
Momentum Score
25 /100
Company Overview
Enspire DBS Therapy, Inc. is a medical device company developing an implantable neuromodulation therapy using deep brain stimulation (DBS) to restore motor function in stroke survivors.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Hardware Sales, Hardware + Subscription
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Enspire DBS Therapy Comps
Public and private peers based on sector, stage, and business model.
Enspire DBS Therapy Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B Extension | Jan 13, 2026 | ||||
| Series B | Aug 1, 2023 | ||||
| Early Funding | Dec 4, 2016 |
Enspire DBS Therapy Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Genesys Capital | Series B Extension |
| JobsOhio Ventures | Series B Extension |
Enspire DBS Therapy Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Enspire DBS Therapy's valuation, stock price, and market status.
